Therapeutic potential of anti-IL-1β IgY in guinea pigs with allergic asthma induced by ovalbumin

Molecular Immunology

Volumn 58, Issue 1, 2014, Pages 139-149

  Wei xu, Hu ^a   Qin, Xiang ^b   Zhu, Wen ^c   Yuan yi, Chen ^b   Li feng, Zeng ^b   Zhi yong, Liu ^d   Dan, He ^b   Xiao mu, Wu ^b   Guo zhu, Hu ^b  

^a FUDAN UNIVERSITY   (China)

^b Jiangxi Province People's Hospital   (China)

^c Jiangxi Institute of Medical Science   (China)

^d Jiangxi Institute of Occupational Disease Prevention   (China)

Author keywords

Allergic asthma; Cytokines; Guinea pigs; Immunoglobulin yolk; Interleukin 1 ; OVA

Indexed keywords

BUDESONIDE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN Y; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 8; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GUINEA PIG; INFLAMMATORY CELL; LUNG LAVAGE; LYMPHOCYTE; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

AHR; AIRWAY HYPERRESPONSIVENESS; ALLERGIC ASTHMA; ANTI-IGE ANTIBODY; ANTI-TNF-Α ANTIBODY; BALF; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; GUINEA PIGS; HE; HEMATOXYLIN-EOSIN; IGE; IGY; IL-1 RECEPTOR ANTAGONIST; IL-13; IL-1RA; IL-1Β; IL-4; IL-8; IMMUNOGLOBULIN E; IMMUNOGLOBULIN YOLK; INFLIXIMAB; INTERLEUKIN-13; INTERLEUKIN-1BETA; INTERLEUKIN-1Β; INTERLEUKIN-4; INTERLEUKIN-8; OMALIZUMAB; OVA; OVALBUMIN; PB; PERIPHERAL BLOOD; SOLUBLE TNF-Α RECEPTOR; SPECIFIC AIRWAY RESISTANCE; SRAW; STNFR; T HELPER TYPE 2; TGF-Β(1); TH2; TNF-Α; TRANSFORMING GROWTH FACTOR-BETA 1; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; BUDESONIDE; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; GUINEA PIGS; IMMUNOGLOBULIN E; IMMUNOGLOBULINS; INFLAMMATION; INTERLEUKIN-1BETA; MALE; NEUTROPHILS; OVALBUMIN;

EID: 84890595719     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.11.006     Document Type: Article

References (34)

1. Antoniu S.A. Cytokine antagonists for the treatment of asthma: progress to date. BioDrugs 2009, 23:241-251. [PMID: 19697966].
2. Bazán-Perkins B., Sánchez-Guerrero E., Vargas M.H., et al. Beta1-integrins shedding in a guinea-pig model of chronic asthma with remodelled airways. Clin. Exp. Allergy 2009, 39:740-751. [PMID: 19302253].
3. Berry M.A., Hargadon B., Shelley M., et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N. Engl. J. Med. 2006, 354:697-708. [PubMed: 16481637].
4. Besnard A.G., Togbe D., Couillin I., et al. Inflammasome-IL-1-Th17 response in allergic lung inflammation. J. Mol. Cell Biol. 2012, 4:3-10. [PMID: 22147847].
5. Brown S.D., Baxter K.M., Stephenson S.T., Esper A.M., Brown L.A., Fitzpatrick A.M. Airway TGF-β1 and oxidant stress in children with severe asthma: association with airflow limitation. J. Allergy Clin. Immunol. 2012, 129:388-396.e8. [PMID: 22206775].
6. Cardell L.O., Uddman R., Zhang Y., Adner M. Interleukin-1beta up-regulates tumor necrosis factor receptors in the mouse airways. Pulm. Pharmacol. Ther. 2008, 21:675-681. [PMID: 18515164].
7. Chang H.C., Gong C.C., Chen J.L., Mak O.T. Inhibitory effects of inhaled complex traditional Chinese medicine on early and late asthmatic responses induced by ovalbumin in sensitized guinea pigs. BMC Complement Altern. Med. 2011, 11:80. [PMID: 21943157].
8. Cho J.Y., Pham A., Rosenthal P., Miller M., Doherty T., Broide D.H. Chronic OVA allergen challenged TNF p55/p75 receptor deficient mice have reduced airway remodeling. Int. Immunopharmacol. 2011, 11:1038-1044. [PMID: 21382533].
9. Deveci F., Muz M.H., Ilhan N., Kirkil G., Turgut T., Akpolat N. Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma. Respirology 2008, 13:488-497. [PMID: 18410261].
10. Franova S., Joskova M., Sadlonova V., et al. Experimental model of allergic asthma. Adv. Exp. Med. Biol. 2013, 756:49-55. [PMID: 22836618].
11. Fujisawa T., Velichko S., Thai P., Hung L.Y., Huang F., Wu R. Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm. J. Immunol. 2009, 183:6236-6243. [PMID: 19841186].
12. Holgate S., Smith N., Massanari M., Jimenez P. Effects of omalizumab on markers of inflammation in patients with allergic asthma. Allergy 2009, 64:1728-1736. [PMID: 19839977].
13. Joubert P., Lajoie-Kadoch S., Wellemans V., et al. Expression and regulation of CCL15 by human airway smooth muscle cells. Clin. Exp. Allergy 2012, 42:85-94. [PMID: 22092970].
14. Kang J.Y., Kim J.W., Kim J.S., et al. Inhibitory effects of anti-immunoglobulin E antibodies on airway remodeling in a murine model of chronic asthma. J. Asthma 2010, 47:374-380. [PMID: 20528589].
15. Lai H.Y., Rogers D.F. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy. Curr. Opin. Allergy Clin. Immunol. 2010, 10:67-76. [PMID: 19907312].
16. Lappalainen U., Whitsett J.A., Wert S.E., Tichelaar J.W., Bry K. Interleukin-1β causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am. J. Respir. Cell Mol. Biol. 2005, 32:311-318. [PMID: 15668323].
17. Li T., Lu W.L., Hong H.Y., et al. Pharmacokinetics and anti-asthmatic potential of non-parenterally administered recombinant human interleukin-1 receptor antagonist in animal models. J. Pharmacol. Sci. 2006, 102:321-330. [PMID: 17116976].
18. Lillie R.D. Histopathologic Technic and Practical Histochemistry 1965, McGraw-Hill Book Co, New York. third ed.
19. Mahajan S.G., Mehta A.A. Suppression of ovalbumin-induced Th2-driven airway inflammation by β-sitosterol in a guinea pig model of asthma. Eur. J. Pharmacol. 2011, 650:458-464. [PMID: 20946894].
20. Manetsch M., Seidel P., Heintz U., et al. TLR2 ligand engagement upregulates airway smooth muscle TNFα-induced cytokine production. Am. J. Physiol. Lung Cell Mol. Physiol. 2012, 302:L838-L845. [PMID: 22245999].
21. Manuyakorn W., Kamchaisatian W., Atamasirikul K., Sasisakulporn C., Direkwattanachai C., Benjaponpitak S. Serum TGF-beta1 in atopic asthma. Asian Pac. J. Allergy Immunol. 2008, 26:185-189. [PMID: 19317336].
22. Mizutani N., Inui S., Yoshino S., Nabe T. Intratracheal sensitization/challenge-induced biphasic asthmatic response and airway hyperresponsiveness in guinea pigs. Biol. Pharm. Bull. 2010, 33:1949-1952. [PMID: 21139231].
23. Nam H.S., Lee S.Y., Kim S.J., et al. The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma. Yonsei Med. J. 2009, 50:569-675. [PMID: 19718408].
24. Nilsson E., Kollberg H., Johannesson M., Wejåker P.E., Carlander D., Larsson A. More than 10 years' continuous oral treatment with specific immunoglobulin Y for the prevention of Pseudomonas aeruginosa infections: a case report. J. Med. Food 2007, 10:375-378. PMID: 17651078.
25. Pegorier S., Campbell G.A., Kay A.B., Lloyd C.M. Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). Respir. Res. 2010, 11:85. [PMID: 20573231].
26. Rahman S., Higo-Moriguchi K., Htun K.W., et al. Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients. Vaccine 2012, 30:4661-4669. PMID: 22575165.
27. Szelenyi I., Hochhaus G., Heer S., et al. Loteprednol etabonate: a soft steroid for the treatment of allergic diseases of the airways. Drugs Today (Barc). 2000, 36:313-320. [PMID: 12861354].
28. Toward T.J., Broadley K.J. Early and late bronchoconstrictions, airway hyper-reactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram. Clin. Exp. Allergy 2004, 34:91-102. [PMID: 14720268].
29. Tsukagoshi H., Sakamoto T., Xu W., Barnes P.J., Chung K.F. Effect of interleukin-1 beta on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats. J. Allergy Clin. Immunol. 1994, 93:464-469. [PMID: 8120273].
30. Worledge K.L., Godiska R., Barrett T.A., Kink J.A. Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats. Dig. Dis. Sci. 2000, 45:2298-2305. PMID: 11258548.
31. Yadav U.C., Ramana K.V., Srivastava S.K. Aldose reductase inhibition suppresses airway inflammation. Chem. Biol. Interact. 2011, 191:339-345. [PMID: 21334316].
32. Zhang Y., Adner M., Cardell L.O. IL-1beta-induced transcriptional up-regulation of bradykinin B1 and B2 receptors in murine airways. Am. J. Respir. Cell Mol. Biol. 2007, 36:697-705. [PMID: 17255557].
33. Zhu M., Flynt L., Ghosh S., et al. Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 2011, 45:111-119. [PMID: 20870897].
34. Zosky G.R., Larcombe A.N., White O.J., et al. Ovalbumin-sensitized mice are good models for airway hyperresponsiveness but not acute physiological responses to allergen inhalation. Clin. Exp. Allergy 2008, 38:829-838. [PMID: 18070158].